In contrast, in NSCLC, a report suggests that IFIT3 might, however, act to promote cancer progression via its upregulation by COL8A1 and subsequent mediation of EGFR activation, a major factor in pathogenesis of this disease [19]. Here, IFIT3 is linked to cancer.